Ischemic stroke is associated with the ABO locus: The EuroCLOT study
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Objective: End‐stage coagulation and the structure/function of fibrin are implicated in the pathogenesis of ischemic stroke. We explored whether genetic variants associated with end‐stage coagulation in healthy REFVIDunteers account for the genetic predisposition to ischemic stroke and examined their influence on stroke subtype. Methods: Common genetic variants identified through genome‐wide association studies of coagulation factors and fibrin structure/function in healthy twins (n = 2,100, Stage 1) were examined in ischemic stroke (n = 4,200 cases) using 2 independent samples of European ancestry (Stage 2). A third clinical collection having stroke subtyping (total 8,900 cases, 55,000 controls) was used for replication (Stage 3). Results: Stage 1 identified 524 single nucleotide polymorphisms (SNPs) from 23 linkage disequilibrium blocks having significant association (p < 5 × 10–8) with 1 or more coagulation/fibrin phenotypes. The most striking associations included SNP rs5985 with factor XIII activity (p = 2.6 × 10–186), rs10665 with FVII (p = 2.4 × 10–47), and rs505922 in the ABO gene with both von Willebrand factor (p = 4.7 × 10–57) and factor VIII (p = 1.2 × 10–36). In Stage 2, the 23 independent SNPs were examined in stroke cases/noncases using MOnica Risk, Genetics, Archiving and Monograph (MORGAM) and Wellcome Trust Case Control Consortium 2 collections. SNP rs505922 was nominally associated with ischemic stroke (odds ratio = 0.94, 95% confidence interval = 0.88–0.99, p = 0.023). Independent replication in Meta‐Stroke confirmed the rs505922 association with stroke, beta (standard error, SE) = 0.066 (0.02), p = 0.001, a finding specific to large‐vessel and cardioembolic stroke (p = 0.001 and p = < 0.001, respectively) but not seen with small‐vessel stroke (p = 0.811). Interpretation: ABO gene variants are associated with large‐vessel and cardioembolic stroke but not small‐vessel disease. This work sheds light on the different pathogenic mechanisms underpinning stroke subtype. Ann Neurol 2013
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
A new multipoint method for genome-wide association studies by imputation of genotypes
Marchini, J., Howie, B., Myers, S., McVean, G., & Donnelly, P. (2007) · Nature Genetics · doi:10.1038/ng2088 · Cited by 2,609
Genomewide Association Analysis of Coronary Artery Disease
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072366 · Cited by 2,044 · cited 1×
“GWA studies have identified common genetic loci of small effect associated with clinical phenotypes such as coronary artery disease.(5) The GWA method allows an agnostic study of variation within the genome, unbiased by prior knowledge of the cellular pathways involved or the use of candidate genes, and has been succe…”
BackgroundLarge-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Self-citationHuman metabolic individuality in biomedical and pharmaceutical research
CARDIoGRAM, Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., et al. (2011) · Nature · doi:10.1038/nature10354 · Cited by 1,017 · cited 1×
“A previous GWA study identified the same SNP, rs505922, to be associated with venous thromboembolism,(30) and a recent GWA study of blood metabolites suggests that this locus may act via an effect on fibrinogen phosphorylation.(31) Our results demonstrate that the association between ABO SNPs and ischemic stroke is li…”
ResultSelf-citationA sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke
Gudbjartsson, D. F., Holm, H., Gretarsdottir, S., Thorleifsson, G., Walters, G. B., Thorgeirsson, G., Gulcher, J., Mathiesen, E. B., Njølstad, I., Nyrnes, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.417 · Cited by 489
Self-citationAndrew, T., Hart, D. J., Snieder, H., de Lange, M., Spector, T. D., & MacGregor, A. J. (2001) · Twin Research · doi:10.1375/1369052012803 · Cited by 440
Self-citationFreeman, M. S., Mansfield, M. W., Barrett, J. H., & Grant, P. J. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00843.x · Cited by 101
Self-citationFreeman, M. S., Mansfield, M. W., Barrett, J. H., & Grant, P. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.104906 · Cited by 82
Self-citation
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationStroke risk factors, genetics, and prevention
Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.308398 · Cited by 1,952
“After detection of potential disease-causing mutations in initial somewhat smaller European cohorts, MetaStroke confirmed an association of stroke with gene variants in the blood type gene ABO (rs505922), which is associated with levels of the coagulation proteins von Willebrand factor and factor 8; the associations w…”
BackgroundMalik, R., Chauhan, G., Traylor, M., Sargurupremraj, M., Okada, Y., Mishra, A., Rutten-Jacobs, L., Giese, A.-K., van der Laan, S. W., Gretarsdottir, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0058-3 · Cited by 1,599
Self-citationAssociations between blood type and COVID-19 infection, intubation, and death
Zietz, M., Zucker, J., & Tatonetti, N. P. (2020) · Nature Communications · doi:10.1038/s41467-020-19623-x · Cited by 581
Dichgans, M., Malik, R., König, I. R., Rosand, J., Clarke, R., Gretarsdottir, S., Thorleifsson, G., Mitchell, B. D., Assimes, T. L., Levi, C., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.002707 · Cited by 329
Self-citation
Metadata
- Authors
- Williams, F. M. K., Carter, A. M., Hysi, P. G., Surdulescu, G., Hodgkiss, D., Soranzo, N., Traylor, M., Bevan, S., Dichgans, M., Rothwell, P. M. W., Sudlow, C., Farrall, M., Silander, K., Kaunisto, M., Wagner, P., Saarela, O., Kuulasmaa, K., Virtamo, J., Salomaa, V., Amouyel, P., Arveiler, D., Ferrieres, J., Wiklund, P., Arfan Ikram, M., Hofman, A., Boncoraglio, G. B., Parati, E. A., Helgadottir, A., Gretarsdottir, S., Thorsteinsdottir, U., Thorleifsson, G., Stefansson, K., Seshadri, S., DeStefano, A., Gschwendtner, A., Psaty, B., Longstreth, W., Mitchell, B. D., Cheng, Y., Clarke, R., Ferrario, M., Bis, J. C., Levi, C., Attia, J., Holliday, E. G., Scott, R. J., Fornage, M., Sharma, P., Furie, K. L., Rosand, J., Nalls, M., Meschia, J., Mosely, T. H., Evans, A., Palotie, A., Markus, H. S., Grant, P. J., Spector, T. D., & on Behalf of the EuroCLOT Investigators the Wellcome Trust Case Control Consortium 2 MOnica Risk, G.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2013-01
- Volume
- 73
- Issue
- 1
- Pages
- 16-31
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2117419192
- Cited by
- 147
- References
- 10
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.